chr12-30634125-T-C

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_006390.4(IPO8):​c.2857A>G​(p.Asn953Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000173 in 1,613,878 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00018 ( 0 hom. )

Consequence

IPO8
NM_006390.4 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 1.30

Publications

3 publications found
Variant links:
Genes affected
IPO8 (HGNC:9853): (importin 8) The importin-alpha/beta complex and the GTPase Ran mediate nuclear import of proteins with a classical nuclear localization signal. The protein encoded by this gene is a member of a class of approximately 20 potential Ran targets that share a sequence motif related to the Ran-binding site of importin-beta. This protein binds to the nuclear pore complex and, along with RanGTP and RANBP1, inhibits the GAP stimulation of the Ran GTPase. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2010]
IPO8 Gene-Disease associations (from GenCC):
  • VISS syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.017588794).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000125 (19/152174) while in subpopulation NFE AF = 0.000191 (13/68008). AF 95% confidence interval is 0.000112. There are 0 homozygotes in GnomAd4. There are 6 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IPO8NM_006390.4 linkc.2857A>G p.Asn953Asp missense_variant Exon 23 of 25 ENST00000256079.9 NP_006381.2 O15397-1
IPO8NM_001190995.2 linkc.2242A>G p.Asn748Asp missense_variant Exon 19 of 21 NP_001177924.1 O15397-2
IPO8XM_017018691.3 linkc.2806A>G p.Asn936Asp missense_variant Exon 23 of 25 XP_016874180.1
IPO8XM_017018692.2 linkc.2671A>G p.Asn891Asp missense_variant Exon 22 of 24 XP_016874181.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IPO8ENST00000256079.9 linkc.2857A>G p.Asn953Asp missense_variant Exon 23 of 25 1 NM_006390.4 ENSP00000256079.4 O15397-1
IPO8ENST00000544829.5 linkc.2242A>G p.Asn748Asp missense_variant Exon 19 of 21 2 ENSP00000444520.1 O15397-2
IPO8ENST00000535598.1 linkc.328A>G p.Asn110Asp missense_variant Exon 2 of 3 3 ENSP00000446232.1 H0YH64

Frequencies

GnomAD3 genomes
AF:
0.000125
AC:
19
AN:
152174
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000191
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000239
AC:
60
AN:
251286
AF XY:
0.000221
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000508
Gnomad NFE exome
AF:
0.000422
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000178
AC:
260
AN:
1461704
Hom.:
0
Cov.:
31
AF XY:
0.000168
AC XY:
122
AN XY:
727140
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33476
American (AMR)
AF:
0.00
AC:
0
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39682
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86244
European-Finnish (FIN)
AF:
0.000524
AC:
28
AN:
53414
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.000192
AC:
214
AN:
1111882
Other (OTH)
AF:
0.000282
AC:
17
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
14
27
41
54
68
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000125
AC:
19
AN:
152174
Hom.:
0
Cov.:
32
AF XY:
0.0000807
AC XY:
6
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41450
American (AMR)
AF:
0.00
AC:
0
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.000471
AC:
5
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000191
AC:
13
AN:
68008
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000237
Hom.:
0
Bravo
AF:
0.000132
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.000346
AC:
42
EpiCase
AF:
0.000327
EpiControl
AF:
0.000178

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Jun 21, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2857A>G (p.N953D) alteration is located in exon 23 (coding exon 23) of the IPO8 gene. This alteration results from a A to G substitution at nucleotide position 2857, causing the asparagine (N) at amino acid position 953 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Uncertain:1
May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

IPO8: PM2, BP4 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
16
DANN
Benign
0.88
DEOGEN2
Benign
0.055
T;.
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.87
FATHMM_MKL
Benign
0.72
D
LIST_S2
Benign
0.68
T;T
M_CAP
Benign
0.013
T
MetaRNN
Benign
0.018
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.58
N;.
PhyloP100
1.3
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-0.10
N;N
REVEL
Benign
0.067
Sift
Benign
0.45
T;T
Sift4G
Benign
0.46
T;T
Polyphen
0.0
B;.
Vest4
0.15
MVP
0.45
MPC
0.30
ClinPred
0.023
T
GERP RS
-0.17
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.041
gMVP
0.091
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140391492; hg19: chr12-30787059; API